| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7902 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.6154 |
| P-glycoprotein Substrate | Substrate | 0.6126 |
| P-glycoprotein Inhibitor | Inhibitor | 0.7355 |
| Non-inhibitor | 0.7629 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6165 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8478 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7085 |
| CYP450 2D6 Substrate | Non-substrate | 0.7220 |
| CYP450 3A4 Substrate | Substrate | 0.7015 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.5068 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.7889 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.7603 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.7941 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6915 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.9322 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6042 |
| Inhibitor | 0.8368 |
| AMES Toxicity | Non AMES toxic | 0.5606 |
| Carcinogens | Non-carcinogens | 0.6802 |
| Fish Toxicity | High FHMT | 0.9992 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9886 |
| Honey Bee Toxicity | Low HBT | 0.9320 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.5539 |
| Carcinogenicity (Three-class) | Non-required | 0.5278 |